Text Size
Obesity Drugs
Results 1 - 2 of 2
In Jan 2011 VIVUS, Inc. announced that it held a meeting with the US FDA for the New Drug Application for QNEXA. The FDA requested that VIVUS assess the feasibility of analyzing existing healthcare databases to determine the historical incidence of oral cleft in offspring of women treated with topiramate for migraine prophylaxis (100 mg). VIVUS anticipates continued dialog with ...
Read More...
Hits517
Updated30 March 2011
Arena finished clinical testing of lorcaserin in 2009, and filed for Food and Drug Administration approval in December.
Hits376
Updated28 May 2010
About - Terms of use - Privacy Policy
Upgrade Your Body (TM) is managed by Consolidated Computing Pty Ltd.